Market Cap 198.79M
Revenue (ttm) 37.76M
Net Income (ttm) 15.89M
EPS (ttm) N/A
PE Ratio 14.30
Forward PE N/A
Profit Margin 42.08%
Debt to Equity Ratio 0.11
Volume 3,800
Avg Vol 9,504
Day's Range N/A - N/A
Shares Out 12.23M
Stochastic %K 92%
Beta 0.36
Analysts Strong Sell
Price Target $22.00

Latest News on SWKH

SWK Holdings Provides Portfolio Update

Jan 6, 2025, 7:35 AM EST - 11 days ago

SWK Holdings Provides Portfolio Update


SWK Holdings Corporation (SWKH) Q1 2024 Earnings Call Transcript

May 17, 2024, 9:06 PM EDT - 8 months ago

SWK Holdings Corporation (SWKH) Q1 2024 Earnings Call Transcript


SWK Holdings Appoints Jerry Albright to Board of Directors

Mar 15, 2023, 4:05 PM EDT - 2 years ago

SWK Holdings Appoints Jerry Albright to Board of Directors


SWK Holdings Corporation (SWKH) Q3 2022 Earnings Call Transcript

Nov 11, 2022, 11:23 AM EST - 2 years ago

SWK Holdings Corporation (SWKH) Q3 2022 Earnings Call Transcript


SWK Holdings Announces Leadership Transition

Sep 1, 2022, 7:30 AM EDT - 2 years ago

SWK Holdings Announces Leadership Transition


Enteris BioPharma to Exhibit at CPhI North America 2022

May 4, 2022, 8:30 AM EDT - 2 years ago

Enteris BioPharma to Exhibit at CPhI North America 2022